MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer
Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer
Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer
Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer
Journal Article

Circulating Thrombospondin‐4‐Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer

2026
Request Book From Autostore and Choose the Collection Method
Overview
Background Cancer‐associated fibroblasts (CAFs) have been reported to be tumor‐specific cells. We have recently reported that thrombospondin‐4 (THBS4) expression is exclusive to CAFs. This study aimed to clarify whether the identification of circulating CAFs (cir‐CAFs) by THBS4 is detectable in the blood of gastric cancer (GC) patients, and whether cir‐CAFs are useful for the screening test of GC. Materials and Methods CAFs and normal fibroblasts (NFs) were respectively established from 17 GC specimens. A total of 24 healthy volunteers and 77 GC patients were enrolled. Flow cytometric analysis was performed using anti‐THBS4 antibody. The sensitivity and specificity of THBS4‐positive cir‐CAFs for detection of GC were calculated. Results THBS4+ cells showed ovoid‐like cells and expressed THBS4. THBS4+ expression was significantly (p = 0.014) higher on CAFs than NFs. GC patients had a significantly (p = 0.0323) higher average number of THBS4‐positive cir‐CAFs than healthy volunteers: 212 cells versus 6.4 cells. The ROC curve indicated that 27 THBS4‐positive cells per 10,000 blood cells was an adequate cutoff for GC diagnosis. The sensitivity and specificity of cir‐CAFs were 76.6% and 100%, respectively. In contrast, the sensitivities of CEA and CA19‐9 were only 22.1% and 9.1%, respectively. The sensitivity of cir‐CAFs was high even for Stage I GC, at 73.5%, while the sensitivity of CEA and CA19‐9 was low at 14.7% and 0%, respectively. Conclusion THBS4‐positive cir‐CAFs are detectable in the blood of GC patients. The cir‐CAFs might be a useful tumor marker in a GC screening test, especially for early‐stage GC.